
Tylosin Market Report 2026
Global Outlook – By Type (Tylosin Tartrate, Tylosin Phosphate, Other Types), By Application (Animal Feed Additives, Animal Drugs, Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) – Market Size, Trends, Strategies, and Forecast to 2035
Tylosin Market Overview
• Tylosin market size has reached to $0.79 billion in 2025 • Expected to grow to $1 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Meat Production Driving Growth In The Tylosin Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Tylosin Market?
Tylosin is an antibiotic medication in the macrolide class commonly used in veterinary medicine to treat various bacterial infections in animals, particularly in livestock such as cattle, swine, poultry, and companion animals like dogs and cats. It is a crucial antibiotic medication used in veterinary medicine to treat bacterial infections in animals, contributing to the health and welfare of livestock and companion animals. The main types of tylosin software are tylosin tartrate, tylosin phosphate and others. Tylosin tartrate is a form of the antibiotic tylosin commonly used in veterinary medicine to treat bacterial infections in livestock. For applications such as animal feed additives, animal drugs, and other applications and it is distributed through hospital pharmacies, drug stores retail pharmacies, and online providers.
What Is The Tylosin Market Size and Share 2026?
The tylosin market size has grown strongly in recent years. It will grow from $0.79 billion in 2025 to $0.83 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to growth of commercial livestock farming, widespread bacterial infections in animals, established efficacy of macrolide antibiotics, expansion of veterinary healthcare services, rising global meat consumption.What Is The Tylosin Market Growth Forecast?
The tylosin market size is expected to see steady growth in the next few years. It will grow to $1 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for protein-rich diets, growth in commercial animal farming, rising investments in veterinary care, expansion of animal health regulations, increasing adoption of preventive veterinary treatments. Major trends in the forecast period include rising demand for veterinary antibiotics, growing use in livestock disease management, increasing focus on animal health and welfare, expansion of poultry and swine farming, higher monitoring of antibiotic usage in animals.Global Tylosin Market Segmentation
1) By Type: Tylosin Tartrate, Tylosin Phosphate, Other Types 2) By Application: Animal Feed Additives, Animal Drugs, Other Applications 3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers Subsegment: 1) By Tylosin Tartrate: Injectable Tylosin Tartrate, Oral Soluble Tylosin Tartrate, Water-Soluble Tylosin Tartrate, Veterinary-Grade Tylosin Tartrate 2) By Tylosin Phosphate: Feed-Grade Tylosin Phosphate, Water-Soluble Tylosin Phosphate, Premix Tylosin Phosphate, Medicated Feed Tylosin Phosphate 3) By Other Types: Tylosin Base, Tylosin Complexes and Blends, Customized Veterinary Tylosin Formulations, Combination Antibiotic Formulations Containing TylosinWhat Are The Drivers Of The Tylosin Market?
The increase in meat production is expected to propel the growth of the tylosin market going forward. Meat production refers to the raising, slaughtering, and processing of animals to obtain meat for human consumption. The increase in meat production is due to growing consumer demand for high-protein diets driven by shifting nutrition preferences. The tylosin market supports expanding livestock output by maintaining herd health through effective treatment of respiratory and gastrointestinal bacterial infections. For instance, in July 2024, according to the Department for Environment Food and Rural Affairs, a UK-based government department, the total animal feed production amounted to 29,397 units in 2022 and increased to 31,128 units in 2023. Therefore, the increase in meat production is driving the growth of the tylosin industry. The growth and modernization of livestock farming is expected to propel the growth of the tylosin market going forward. Modernization of livestock farming refers to the adoption of advanced technologies, improved management practices, and efficient production systems to enhance animal health, productivity, and sustainability in livestock operations. Growth and modernization of livestock farming are primarily driven by the increasing demand for high-quality animal products, which encourages farmers to adopt advanced practices, technologies, and efficient management systems. Tylosin supports livestock farming by helping maintain animal health and productivity through effective control of bacterial infections, ultimately enabling more efficient and sustainable farm operations. For instance, in January 2024, according to the Government Accountability Office, a US-based government agency, in 2023, 27% of farms and ranches in the U.S. adopted precision agriculture practices for managing crops or livestock. Therefore, the growth and modernization of livestock farming is driving the growth of the tylosin industry. The expansion of the veterinary pharmaceutical industry is expected to propel the growth of the tylosin market going forward. The veterinary pharmaceutical industry refers to the sector that develops, manufactures, and distributes medicines, vaccines, and health products specifically designed to prevent, treat, and manage diseases in animals. Expansion of the veterinary pharmaceutical industry is primarily due to increasing pet ownership, which drives higher demand for advanced animal health products and veterinary treatments. Expansion of the veterinary pharmaceutical industry supports the growth of the tylosin market by driving greater demand for effective antimicrobial treatments that help maintain animal health and productivity. For instance, in February 2025, according to the Competition and Markets Authority (CMA), a UK-based government department, in 2023, consumer spending on veterinary and other pet services amounted to around $7.84. Therefore, the expansion of the veterinary pharmaceutical industry is driving the growth of the tylosin industry.Key Players In The Global Tylosin Market
Major companies operating in the tylosin market are Zoetis Inc., Elanco Animal Health Inc., Ceva Santé Animale, Phibro Animal Health Corporation, Huvepharma AD, Vetoquinol S.A., Norbrook Inc., Shandong Lukang Pharmaceutical Co. Ltd., Qilu Animal Health Products Co. Ltd., Hebei Veyong Animal Pharmaceutical, Apeloa Pharmaceutical Co. Ltd., Suanfarma SA, AdvaCare Pharma, Ningxia Tairui Pharmaceutical Co. Ltd., Pucheng Chia Tai Biochemistry Co. Ltd., Anhui Sinotech Industrial, Rochem International Inc., Vetgen Healthcare Pvt. Ltd., Sunvet Pharma Private Ltd., Nestlife Science Pvt. Ltd.Regional Insights
North America was the largest region in the tylosin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Tylosin Market?
The tylosin market consists of sales of oral powders, premixes, water-soluble powders, and injectable solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Tylosin Market Report 2026?
The tylosin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tylosin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Tylosin Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.83 billion |
| Revenue Forecast In 2035 | $1 billion |
| Growth Rate | CAGR of 5.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, Distribution Channel, Tylosin Tartrate, Tylosin Phosphate, Other Types |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Zoetis Inc., Elanco Animal Health Inc., Ceva Santé Animale, Phibro Animal Health Corporation, Huvepharma AD, Vetoquinol S.A., Norbrook Inc., Shandong Lukang Pharmaceutical Co. Ltd., Qilu Animal Health Products Co. Ltd., Hebei Veyong Animal Pharmaceutical, Apeloa Pharmaceutical Co. Ltd., Suanfarma SA, AdvaCare Pharma, Ningxia Tairui Pharmaceutical Co. Ltd., Pucheng Chia Tai Biochemistry Co. Ltd., Anhui Sinotech Industrial, Rochem International Inc., Vetgen Healthcare Pvt. Ltd., Sunvet Pharma Private Ltd., Nestlife Science Pvt. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
